← SynDRA
VORASIDENIB
SynDRA canonical compound SYN0039351 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | IDH1 |
|---|
| Mechanism of action | isocitrate dehydrogenase inhibitor |
|---|
All known targets
- IDH1
- IDH1; IDH2; IDH3A; IDH3B; IDH3G
- IDH2
Mechanisms of action (all sources)
- IDH1 INHIBITOR
- IDH1/IDH2 inhibitor
- IDH2 INHIBITOR
- Isocitrate dehydrogenase [NADP], mitochondrial inhibitor
- Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
- isocitrate dehydrogenase inhibitor
- Inhibitor
Drug classes
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- AG-881
- Voranigo
- AG 881
- UNII-789Q85GA8P
- 789Q85GA8P
- AG881
- 9UO
- 6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine
- Vorasidenib [INN]
- Vorasidenib (AG-881)
- SCHEMBL16393139
- AG 881 [WHO-DD]
- QCZAWDGAVJMPTA-RNFRBKRXSA-N
- BDBM279948
- EX-A2574
- US10028961, Compound 101
- s8611
- CS-8033
- HY-104042
- 6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoro propan-2-yl)-1,3,5-triazine-2,4-diamine
- 6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoroprop
- vorasidenibum
- RefChem:902054
- Vorasidenib [USAN]
- Vorasidenib (AG881)
- AG-881; Vorasidenib
- Vorasidenib (USAN/INN)
- Vorasidenib [USAN:INN]
- VORASIDENIB [WHO-DD]
- C14H13ClF6N6
- orb1299935
- SCHEMBL22396621
- SCHEMBL22396622
- SCHEMBL22396628
- SCHEMBL22396629
- SCHEMBL23573057
- SCHEMBL23573058
- SCHEMBL23573059
- SCHEMBL23573061
Look up VORASIDENIB in the interactive SynDRA portal →